4
Changes in Ownership
Sonoma Pharmaceuticals, Inc. Filed Acc 0001209191-10-016420
Chief Executive Officer sold 15,000 shares at $3.16 ($47,343)
- Chief Executive Officer acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Alimi Hojabr · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2010-03-09 | Exercise or conversion : show line 1 in the form | +15,000 | $1.10 | $16,500 | 1,026,250 | D |
| 2010-03-10 | Sale : show line 2 in the form | −15,000 | $3.16 | $47,343 | 1,011,250 | D |
| Open-market sales · 15,000 sh · avg $3.16 · $47,343 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2010-03-09 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −15,000 | $1.10 | $16,500 | $1.10 | 2010-03-20 | 15,000 | 328,070 | D |
Loading xslF345X03/doc4.xml…